The estimated Net Worth of Kimberley A. Elting is at least $2.62 Million dollars as of 18 November 2021. Ms. Elting owns over 1,000 units of Orthofix Medical Inc stock worth over $814,372 and over the last 8 years she sold OFIX stock worth over $0. In addition, she makes $1,809,760 as Chief Legal and Administrative Officer at Orthofix Medical Inc.
Sign up
Ms. Elting OFIX stock SEC Form 4 insiders trading
Kimberley has made over 2 trades of the Orthofix Medical Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 1,000 units of OFIX stock worth $30,340 on 18 November 2021.
The largest trade she's ever made was exercising 7,000 units of Orthofix Medical Inc stock on 2 November 2018 worth over $300,230. On average, Kimberley trades about 222 units every 31 days since 2016. As of 18 November 2021 she still owns at least 46,803 units of Orthofix Medical Inc stock.
You can see the complete history of Ms. Elting stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kimberley Elting biography
Kimberley A. Elting is Chief Legal and Administrative Officer of the Company. Ms. Elting joined Orthofix as Chief Legal Officer in September 2016 and was named Chief Legal and Administrative Officer in 2017. Before joining the Company, she had served since 2013 as General Counsel and Vice President Corporate Affairs at TriVascular Technologies, Inc. In this role, she led the legal, compliance, human resources (HR) and government affairs functions. Between 2007 and 2012, she served in various roles of increasing responsibility with St. Jude Medical, including General Counsel and Vice President of HR and Health Policy for the Neuromodulation Division. She also previously was a partner at the Jones Day law firm where she counseled clients in the health care sector on mergers and acquisitions and regulatory matters. A graduate of Ithaca College, Ms. Elting earned her Law Degree from the University of Denver and an LL.M. in Health Law from Loyola University Chicago.
What is the salary of Kimberley Elting?
As the Chief Legal and Administrative Officer of Orthofix Medical Inc, the total compensation of Kimberley Elting at Orthofix Medical Inc is $1,809,760. There are 2 executives at Orthofix Medical Inc getting paid more, with Jon Serbousek having the highest compensation of $4,076,200.
How old is Kimberley Elting?
Kimberley Elting is 55, she's been the Chief Legal and Administrative Officer of Orthofix Medical Inc since 2017. There are 10 older and 4 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
What's Kimberley Elting's mailing address?
Kimberley's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Insiders trading at Orthofix Medical Inc
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth und Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
What does Orthofix Medical Inc do?
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
What does Orthofix Medical Inc's logo look like?
Complete history of Ms. Elting stock trades at Orthofix Medical Inc
Orthofix Medical Inc executives and stock owners
Orthofix Medical Inc executives and other stock owners filed with the SEC include:
-
Jon Serbousek,
President, Chief Executive Officer, Director -
Douglas Rice,
Chief Financial Officer -
Kimberley Elting,
Chief Legal and Administrative Officer -
Jon C. Serbousek,
Pres, CEO & Director -
Kevin J. Kenny,
Pres of Global Spine Bus. -
Douglas C. Rice,
CFO & Chief Accounting Officer -
Kimberley A. Elting,
Chief Legal & Devel. Officer -
Ronald Matricaria,
Independent Chairman of the Board -
Paul W. Gonsalves,
Pres of Global Orthofix Orthopedics -
Michael Paolucci,
Independent Director -
James Hinrichs,
Independent Director -
Alexis Lukianov,
Independent Director -
Maria Sainz,
Independent Director -
Lilly Marks,
Independent Director -
John Sicard,
Independent Director -
Paul Gonsalves,
President of the Orthofix Global Extremities -
Jason Hannon,
Independent Director -
Kevin Kenny,
President, Global Orthofix Spine -
Suzanne Armstrong,
VP of HR -
Jill Mason,
Chief Ethics & Compliance Officer -
Dan E. Yarbrough,
VP of Investor Relations -
Tim McGuire,
Chief Information Officer -
Dr. James T. Ryaby B.A., Ph.D., Chemistry,
Chief Scientific Officer -
Roberto Donadello,
Sr. VP, Global Operations -
Michael Finegan,
-
Robert Allen Ii Goodwin,
President Biologics -
Rice Doug,
CFO -
Raymond Fujikawa,
President Spine Fixation -
Davide Bianchi,
President, Global Extremities -
Guy J Jordan,
Director -
Anthony Francis Martin,
Director -
Luke T Faulstick,
Director -
Bradley V. Niemann,
President of Global Spine -
Jeffrey Schumm,
SVP,General Counsel -
Charles R. Kummeth,
-
John J. Bostjancic,
CFO -
Keith Valentine,
President & CEO -
John B Iii Henneman,
-
Patrick L Keran,
Chief Legal Officer -
Stuart Essig,
Director -
Brad Mason,
CEO -
Massimo Calafiore,
President & CEO -
Eric M Brown,
Sr.V.P. of Sales and Marketing -
De Paul Alberto C Dabreu,
Director -
John W Littlechild,
Director -
Cooper Robert Gaines,
Chairman -
Davey Scoon,
Director -
Emily Buxton,
Int. Chief Financial Officer -
James Gero,
Director -
Wartburg Walter P Von,
Director -
Randy H Thurman,
Director -
Mark A Heggestad,
Chief Financial Officer -
Michael Mainelli,
Director -
Scott Dodson,
President, Orthopedics -
Kenneth R Weisshaar,
Director -
Kathleen T Regan,
Director -
Thomas M Hein,
Chief Financial Officer -
Gary Henley,
President, Americas Division -
Peter J Hewett,
Director -
Oliver Burckhardt,
President, International Div -
Alan Milinazzo,
Chief Operating Officer -
Galvin Mould,
President, International Div -
Frederik Hartsuiker,
Director -
Edgar Wallner,
Deputy Chairman -
Peter Clarke,
Executive Vice President -
Robert S Vaters,
Chief Financial Officer -
Stefan Widensohler,
Director -
Thomas J Kester,
Director -
Timothy M Adams,
Chief Financial Officer -
Charles Federico,
President & CEO -
Vicente Trelles,
SVP-Worldwide Operations -
Eric Brown,
President, Spinal Stimulation -
Michael Simpson,
President, Orthofix Inc. -
Bradley R Mason,
President of Breg -
Brian Mc Collum,
Interim CFO -
Jerry Benjamin,
Director -
Raymond C Kolls,
VP & General Counsel -
Bryan Mcmillan,
President, Spine GBU -
Brad Lee,
President, Breg -
Luigi Ferrari,
President, Int'l Fixation -
Shweta Maniar,
-
Julie Andrews,
CFO -
Patrick Fisher,
President, Global Orthopedics -
Jorge Andres Cedron,
CLO -
Wayne Burris,
-
Thomas A. West,
Director -
Puja Leekha,
CECO & Interim CLO -
Geoffrey C Gillespie,
CAO -
Catherine M Burzik,
-
Alan Lee Bazaar,
-
Max Reinhardt,
President, Global Spine